We received the application for a new device category for transitional pass-through payment status for the SCOUT MD TM Surgical Guidance System on August 30, 2024, which is within 3 years of the date of the initial FDA marketing authorization
The peptide appears to promote mucosal healing through enhancement of epithelial cell proliferation and migration, restoration of tight junction integrity, and modulation of inflammatory responses within the gastrointestinal tract
For more information, please visit www.setriaglutathione.com *This information is only intended for business-to-business use
Dosing Protocols and Administration Due to the short half-life, research protocols typically employ bilateral intramuscular injection into target muscles of 20-100 mcg per injection site, administered immediately post-workout when muscle is primed for growth, multiple times per week (not daily, due to potency), with cycling protocols (e.g., 4-6 weeks on, 4-6 off), and often combined with growth hormone or secretagogues